Abstract
The treatment of hypertension with a single daily-dose of a beta-blocker gives rise to high peak-plasma concentrations 1.5 h after ingestion. After slow release-preparations of beta-blockers, the peak concentrations are half those produced by the conventional preparation at the same oral dose. A frequently occurring side-effect of beta-blocker therapy is fatigue. In this study the effect of a single dose of metoprolol 300 mg, 200 mg, 200 mg slow-release and a placebo on maximal exercise power was tested in 6 healthy subjects, 1.5 h and 24 h after ingestion. Maximal exercise power was significantly reduced 1.5 h after ingestion of metoprolol 300 mg and 200 mg. No change was found 1.5 h after 200 mg of a slow-release preparation. The possible reasons for reduced maximal exercise power are discussed. It is concluded that use of a beta-blocker for the treatment of hypertension in a single daily-dose regimen may be a reason to prefer a slow-release preparation.
MeSH Terms
Adult
Blood Pressure/drug effects
Delayed-Action Preparations
Heart Rate/drug effects
Hemodynamics/drug effects
Humans
Male
Metoprolol/administration & dosage,adverse effects,pharmacology
Physical Exertion
Propanolamines/pharmacology
Chemicals
Delayed-Action Preparations
Propanolamines
Metoprolol
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Folgering H
van Bussel M
References (14)
14 references, click to expand
-
Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.
Br Heart J. 1979 Jan;41(1):99-105
PMID: 371643
-
Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
Br J Clin Pharmacol. 1977 Apr;4(2):147-51
PMID: 861129
-
Beta-blockers: once or three times a day?
Br Med J. 1978 May 27;1(6124):1386-8
PMID: 348260
-
Acute haemodynamic effects of metoprolol in hypertensive patients.
Br J Clin Pharmacol. 1977 Feb;4(1):23-6
PMID: 843419
-
Hemodynamic response to graded exercise after chronic beta-adrenergic blockade.
J Appl Physiol Respir Environ Exerc Physiol. 1977 Feb;42(2):133-8
PMID: 838637
-
Autonomic blocking drugs on circulatory adaptations at rest and during exercise in man. Pronethalol and poldine in long-term treatment.
Acta Med Scand. 1968 Nov;184(5):347-52
PMID: 4389733
-
Oxygen debt: effect of beta-adrenergic blockade on the lactacid and alactacid components.
J Appl Physiol. 1969 Dec;27(6):813-6
PMID: 5353204
-
The effects of propranolol and metoprolol on exercise responses in normal man [proceedings].
Br J Clin Pharmacol. 1978 Nov;6(5):443P
PMID: 728294
-
Effects of propranolol on several physiological responses during orthostatic and exercise stress in healthy male subjects.
Can J Physiol Pharmacol. 1971 Oct;49(10):867-72
PMID: 4400448
-
Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
Eur J Clin Pharmacol. 1979 Mar 26;15(2):97-103
PMID: 436924
-
Hemodynamic response to exercise after propranolol in normal subjects.
Can J Physiol Pharmacol. 1966 May;44(3):465-74
PMID: 5914366
-
Beta-blockade and muscle function.
Lancet. 1978 Dec 16;2(8103):1318-9
PMID: 82832
-
Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.
J Clin Invest. 1965 Nov;44(11):1745-53
PMID: 5843708
-
Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):45-58
PMID: 1079687